One significant advancement in endometrial cancer treatment is the combination of lenvatinib, a targeted therapy, with pembrolizumab, an immunotherapy. A recent phase 3 trial demonstrated that ...
There are already more than hundreds of hormones known to exist in the human body. By sending information to your organs, skin, muscles and other tissues via your blood, hormones help your body ...
GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...
GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...
Treatment for fibroids will depend on the ... care—especially to rule out more serious issues like endometrial cancer. Additional Sources Well+Good articles reference scientific, reliable ...
European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback